Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Artificial Intelligence and Machine Learning in Clinical and Translational Science

Pharmaceutical Research & Manufacturers of America (PhRMA) Foundation

The PhRMA Foundation and ASCPT’s journal Clinical and Translational Science are partnering on a Challenge Award for trainees.

$5,000 Challenge Award for Trainees

The PhRMA Foundation and ASCPT’s journal Clinical and Translational Science (CTS) are partnering on a Challenge Award competition that will award trainees for outstanding papers addressing artificial intelligence (AI) and machine learning (ML) in clinical and translational science.

The PhRMA Foundation will provide the Challenge Award — a prize of $5,000 — to the first author of up to five winning papers, and CTS will publish these accepted manuscripts as part of a special collection. Additionally, the Foundation will pay CTS’s open-access publishing fee for each winning paper.

NEW DEADLINE: April 15, 2025

Scope of the Call

Artificial intelligence (AI) and machine learning (ML) are at the forefront of a revolution in clinical and translational science. These advanced technologies herald a new era of innovation, where complex datasets can be deciphered with unprecedented speed and accuracy, enabling breakthroughs in disease diagnosis, drug discovery/development and precision medicine. In light of the transformative potential of AI/ML, this collection is dedicated to assembling a diverse array of original research articles, reviews, and position papers that expand the frontier of current medical practice and drug discovery and development. Submissions of original research are particularly encouraged.

Areas of interest include, but are not limited to:

Innovations in AI/ML that facilitate translational research from bench to bedside.
Leveraging AI/ML for biomarker identification and qualification.
Applying AI/ML in nonclinical studies.
Integrating AI/ML in clinical trial design, operation, and data analyses.
Utilization of AI/ML to tailor therapeutic strategies to individual patients.
Monitoring drug safety post-marketing using AI/ML tools.
Discussion of the regulatory and ethical considerations in employing AI/ML tools.

Submission Guidelines, Selection Process, and Publication

Authors must submit manuscripts through CTS’s online submission system by April 15, 2025. Authors must indicate in their cover letter that they wish to be considered for the PhRMA Foundation Challenge Award.

Early submissions are welcomed. All submissions will undergo the journal’s peer-review process. All papers accepted for publication by CTS will be published, but only those selected as winners by the PhRMA Foundation will receive the $5,000 Challenge Award and payment for their open-access publication. Challenge Award winners will be determined by members of the Foundation’s Scientific Advisory Committee.

Specialties

Artificial Intelligence

Natural Language Models

Technology Development

Data Science

Others

Eligibility Requirements

First authors must be graduate students, postdoctoral fellows, or clinical residents (e.g., interns, residents, or fellows in medicine or pharmacy.) All award money will be distributed to the first author only.
Papers must be submitted by April 15, 2025.
Authors must indicate in their cover letter that the paper is for the PhRMA Foundation Challenge Award competition.
Employees of pharmaceutical companies are allowed to compete but are not eligible to receive award money due to restrictions on provision of financial awards by the Foundation.

Sponsor Details

Sponsor Institute/Organizations: Pharmaceutical Research & Manufacturers of America (PhRMA) Foundation

Sponsor Type:

Address: 670 Maine Avenue SW, Suite 1000 Washington DC, 20024-3556 (202) 572-7756 info@phrmafoundation.org

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity